Vaginal Delivery for Early Preterm Birth Is Safe
September 3rd 2012With the exception of breech presentations, attempting vaginal delivery of early preterm fetuses in the vertex position is highly successful and associated with neonatal mortality rates similar to those for cesarean delivery.
Read More
Compounded Bioidentical Hormone Therapy for Menopause
August 24th 2012The claims that compounded bioidentical hormones are superior to conventional menopausal hormone therapy are unsupported by evidence, according to a new committee review of compounded bioidentical menopausal hormone therapy.
Read More
Suspected Fetal Compromise: Is Deferred Delivery Best?
August 22nd 2012When fetal compromise is suspected, deferring delivery to allow the fetus more time in the womb until test results worsen or a favorable gestational age has been achieved may improve fetal and maternal outcomes, concluded a new study.
Read More
Lapatinib Plus Trastuzumab Improves Survival in Metastatic Breast Cancer
August 20th 2012In patients with heavily pretreated HER2-positive metastatic breast cancer, combination treatment with lapatinib and trastuzumab was associated with a median survival benefit of 4.5 months, according to the final results of a phase III study.
Read More
Managing Elevated Lead Levels in Pregnancy
August 17th 2012Because lead easily crosses the placenta, elevated lead levels in pregnancy have been associated with gestational hypertension, spontaneous abortion, low birth weight, and impaired neurodevelopment. In a new Committee Opinion, The American College of Obstetricians and Gynecologists has reviewed screening and management policies for elevated lead levels in pregnancy.
Read More
Timing of Endometrial Injury Matters in ART
August 15th 2012In women undergoing assisted reproductive techniques, intentional endometrial injury performed in the month prior to the embryo transfer cycle can increase the likelihood of clinical pregnancy and live birth, according to results of a new study.
Read More
Surprising New Research on the Risks for Preterm Birth
August 6th 2012The independent risk factors for spontaneous preterm birth with intact membranes and SPTB after prelabor rupture of membranes for healthy nulliparous pregnant women are markedlydifferent, according to results of a new study.
Read More
Ursodeoxycholic Acid is of Limited Benefit in Obstetric Cholestasis
July 25th 2012Despite insufficient evidence to support the practice, many physicians treat obstetric cholestasis with ursodeoxycholic acid to reduce pruritis and hepatic impairment. Recently, the largest trial to date comparing UDCA with placebo also studied the timing of delivery in this group of women.
Read More
Embolization for Uterine Fibroids Has Benefits, But Still Impacts Reproductive Potential
July 18th 2012In a systematic review of UAE versus other surgical interventions for symptomatic uterine fibroids, researchers concluded that UAE offers substantial improvements in symptoms of uterine fibroids but may not help women who want to retain their reproductive potential.
Read More
Combined Hormonal Birth Control: Fear-Promoting Headlines Just Hype
July 9th 2012In the largest study of its kind, researchers found increased risk for myocardial infarction and thrombotic stroke in women using combined estrogen-progestin contraceptives. However, news headlines tend to overstate the risk, and patients may have new concerns about the safety of their hormonal contraceptive.
Read More
Intrapartum HIV Transmission Rates Halved By Adding Nevirapine
July 6th 2012Combination treatment with nevirapine and zidovudine more effectively reduces intrapartum transmission rates of HIV than treatment with zidovudine alone, according to results of a new study by a National Institutes of Health research network.
Read More